"The physician makes the final decision — I'm just handing over the materials." That sentence is half true and half evasion. I chose the slides. I set up the meeting. I presented the data. I decided what not to say. As long as I am the person who shaped the information the physician received, I cannot separate myself from the outcome. This is a belief I use to remind myself of that fact — quietly, but without room to negotiate.
So what / So why — Why this belief is necessary
Prescribing decisions belong to physicians. That is fixed. But what physicians base those decisions on is substantially controlled by materials authors and medical representatives: which data get presented, which adverse effects get mentioned, what numerical framing is used, what gets left out. Every one of those choices stacks up into the shape of the information a physician actually receives.
The Guidelines on Sales Information Provision Activities for Prescription Drugs (MHLW, September 25, 2019, Yakuseikanma 0925 No. 1) make clear that responsibility rests with the pharmaceutical manufacturer. "The speaker said it" or "the physician asked for it" does not establish grounds for exemption — because the company designed the occasion, delivered the materials, and structured the information flow. Whatever the nominal starting point, the substantive starting point lies with the person who authored the materials.
The externalization of accountability happens without anyone noticing. "The KOL said so." "My manager was in the room, so I assumed it was fine." "The physician asked the question and I answered it." These phrases appear repeatedly across seven years of monitoring program reports. They are not the words of identifiably bad actors — they are what ordinary representatives say naturally when under pressure (see Inside the Author's Head, vol. 06: "Structures That Let You Blame Someone Else"). This belief exists so that I can notice that drift in myself before it hardens.
The belief — What I want to be
I want to be someone who faces the consequences of the information I chose to present.
When I build a slide deck, I am making selections. What goes in and what stays out, which number leads and which gets buried — those choices determine the reality the physician holds in their hands. Having made them, I am responsible for the shape they produced. "The physician makes the final decision" is true, but I am acting as a steward of evidence: my job is to deliver what is needed for that decision without bias. Not to steer it.
Of course I waver. "This dataset alone should be enough." "Framed against the competitor, this layout reads more clearly." "The physician didn't ask, so I skipped it." I know the moment when those justifications surface in my head. That is exactly why I make this a belief — something I can return to when I start to drift.
I want to be someone who also owns what I did not say. "I didn't lie" is not enough. Adverse-effect information I omitted, domestic trial results I passed over, prescribing conditions I never stated explicitly — these are not affirmative falsehoods, but they may have distorted a physician's judgment. Taking responsibility means holding that possibility as mine.
And when a KOL delivers off-label content in a presentation, when my manager stays silent, when a physician's question provides convenient cover — I want to be someone who still cannot say "that had nothing to do with me." If I designed the occasion, I am the starting point.
Daily practice — Concrete actions and checks
- After finishing a piece of materials, list what you left out. Not the data you included — the data you excluded. Adverse effects, domestic trial results, approval conditions, numbers that compare unfavorably to competitors. If you left them out because they were unnecessary for the physician's decision, that is defensible. If you left them out because they were inconvenient, stop.
- When you catch yourself about to say "the physician decides," pause. That phrase tends to appear precisely when you are putting distance between yourself and the consequences of your choices. Noticing that is sometimes enough to change the decision.
- Review KOL presentation materials before the event. Sponsor companies bear responsibility for what speakers say. "The speaker said it" does not exempt the company (Guidelines, Section 3-2(4)). Not reviewing is choosing to discard your own opportunity to catch a problem.
- When your manager is present, check your own explanation yourself. Do not rely on the assumption that your manager will step in. A manager's silence is not approval — it may simply be silence. You are the person responsible for the accuracy of what you said.
- Ask whether the physician-initiated framing was constructed in advance. If the conversation was guided so that the physician appeared to raise a product name first, "I was only responding to a request" does not hold. Ask yourself honestly where the substantive starting point was.
You will not manage this every time. But the standard worth holding is this: can you leave the room feeling that you have owned this piece of materials? If the answer is yes, that is what you are aiming for.
When it is tested — Under pressure
This belief erodes fastest when an exit is sitting right in front of you.
A KOL discusses an off-label use case during a sponsored lecture. The company representative is in the room and says nothing. The next day, a piece of materials circulating internally cites that KOL's remarks as support. "The professor said so" becomes the basis for a claim. The cases recorded in the FY2025 monitoring program report document multiple "not owning it" choices inside exactly that chain of events (see Learning from Past Incidents, vol. 04: "Presenting Unapproved Indications and Dosages").
Quarterly targets are closing in. A competitor product is gaining share. In that context, the thought "let's just show this dataset" will arrive. That is not the thinking of a bad person — it is the thinking of an ordinary person under pressure. That is precisely why the line has to be drawn before the pressure arrives.
There is only one way to draw it. Ask: "If a physician prescribes based on this explanation and something happens afterward, can I own what I said?" If the answer is no, change it. The question is not there to weigh the scale of responsibility — it is there to check whether what you said was honest.
A manager's silence in the room is not approval. The tendency to read a superior's silence as a green light is a mechanism social psychology has documented repeatedly (Stanley Milgram, Obedience to Authority, 1974). The presence of an authority figure compresses an individual's sense of moral responsibility. That is why you have to deliberately check for yourself.
Anchor — Where to return when you are close to breaking
The foundational principle of the Guidelines on Sales Information Provision Activities is to support healthcare professionals in making autonomous judgments based on appropriate information. Support requires that information arrive without bias: both efficacy and safety, a clear distinction between approved and unapproved uses, claims proportionate to the strength of the evidence. Only when all of that is in place is a physician's judgment genuinely supported. When any piece is missing, it becomes steering, not support.
The phrase "although this is off-label" does not provide exemption — that follows directly from the logic of the Guidelines. In each of the seven years from FY2019 through FY2025, cases of providing unapproved information after that very phrase were recorded without exception (see Learning from Past Incidents, vol. 04: "Presenting Unapproved Indications and Dosages"). The disclaimer's presence or absence does not settle the matter — what the information actually does is what counts.
When you are close to breaking, the place to return to is this: "Am I supporting the physician's judgment right now, or am I steering it?" Support requires that information arrive without bias. As long as you can hold that question, you can own your work.
On the days that is hard, recognize it as a hard day. Do not force yourself to feel fine. As long as you still feel the difficulty, some residue of integrity remains. The genuinely dangerous point is when "this is fine" starts to arrive without friction.
As We Should Be ── Ten Convictions for Material Creators ── Map of 10 chapters
- Part 1: Scientific Evidence Steward — I Am Not a Salesperson
- Part 2: Taking Responsibility for the Reader's Mental Image
- Part 3: The Conscience That Doubts Conclusions — Led by Data
- Part 4: Sign the Whole — Not Just One Slide
- Part 5: Duty to Tell — Efficacy and Safety on Equal Footing
- Part 6 (this chapter): Own It — Don't Hide Behind "The Physician Decides"
- Part 7: The Right Distance from Numbers — Quotas as Constraints, Not Goals
- Part 8: Respect for Competitors — Fair Play Builds Trust
- Part 9: Staying Open — Disclosing Limitations, Uncertainty, and Conflicts of Interest on Your Own
- Part 10: Embedding Conscience into the Organization's Systems — From the Individual to the Organization, Made Visible
- "The physician decides" is not an exemption. Once you have chosen the slides, set up the meeting, and determined what to omit, you are a party to the shape of the information that physician received. Attributing the starting point to someone else does not change where the substantive starting point actually was.
- Owning it includes what you did not say. Adverse-effect information left out, domestic trial results passed over, prescribing conditions never stated explicitly — these are not affirmative falsehoods, but they may have distorted a physician's judgment. The Guidelines treat omission as carrying the weight of a deviation, and "I didn't lie" is not enough.
- One question is sufficient to check whether you are owning your work: "If a physician prescribes based on this explanation and something happens afterward, can I own what I said?" If the answer is no, change it. The question is not there to measure the scale of responsibility — it is there to check whether your explanation was honest.
- Guidelines on Sales Information Provision Activities for Prescription Drugs (Ministry of Health, Labour and Welfare, September 25, 2019, Yakuseikanma 0925 No. 1)
- Monitoring Program for Sales Information Provision Activities for Prescription Drugs: Report for FY2019 (MHLW commissioned project)
- Monitoring Program for Sales Information Provision Activities for Prescription Drugs: Report for FY2020 (MHLW commissioned project)
- Monitoring Program for Sales Information Provision Activities for Prescription Drugs: Report for FY2022 (MHLW commissioned project)
- Survey Project on Sales Information Provision Activities for Prescription Drugs: Report for FY2025 (MHLW commissioned project)
- Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (PMD Act), Article 66 (Prohibition of exaggerated advertising) and Article 68 (Prohibition of advertising of pre-approval pharmaceuticals)
- Standards for Appropriate Advertising of Pharmaceuticals (Director, Office of Monitoring and Narcotics, Pharmaceutical Safety and Environmental Health Bureau, MHLW; last revised 2017)
- Guidelines for Preparation of Product Information Summaries for Prescription Drugs (Japan Pharmaceutical Manufacturers Association)
- Stanley Milgram, Obedience to Authority: An Experimental View (Harper & Row, 1974) — the foundational empirical study on how the presence of authority figures compresses individual moral responsibility
- Lee Ross & Richard E. Nisbett, The Person and the Situation: Perspectives of Social Psychology (McGraw-Hill, 1991) — social psychology classic on situational attribution and the gap between actors' self-perception and the substantive origins of their behavior